ClinicalTrials.Veeva

Menu

Interest of Performing Two 6-minute Walk Tests at the End of a Pulmonary Rehabilitation Program, in COPD Patients. (2-TM6)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

COPD

Study type

Observational

Funder types

Other

Identifiers

NCT05850299
29BRC23.0034 - 2-TM6

Details and patient eligibility

About

In pulmonary rehabilitation, the 6-Minute Walk Test (6MWT) is essential to assess the effects of the program on patients' health. Current guidelines don't recommend to perform two 6MWT at the end of pulmonary rehabilitation. However, a more recent study shows that two 6MWT should be performed at the end of the program to accurately and reliably assess patients' capacities.

The aim of this study is to compare the results of two tests performed at the end of the program by COPD patients to find out whether there is a benefit of performing two 6MWT at the end of pulmonary rehabilitation.

Enrollment

176 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with stage 2 to 4 (A to D) COPD
  • Admitted to pulmonary rehabilitation unit of CH des Pays de Morlaix (CHPM)
  • To follow a pulmonary rehabilitation program (4 weeks)
  • Patient aged 18 or over
  • Patient able to formulate his non-opposition to participate in the study

Exclusion criteria

  • Contraindication to perform the 6-Minute Walk Test
  • Patient under legal protection
  • Refusal of participation

Trial contacts and locations

1

Loading...

Central trial contact

Marc BEAUMONT, PhD; Marc BEAUMONT, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems